Adjuvant treatment of colorectal cancer

被引：14

作者：

Beretta, GD ^{[1
]}

Milesi, L ^{[1
]}

Pessi, MA ^{[1
]}

Mosconi, S ^{[1
]}

Labianca, R ^{[1
]}

机构：

[1] Riuniti Hosp, Dept Med Oncol, Gastrointestinal Oncol Unit, I-24128 Bergamo, Italy

来源：

SURGICAL ONCOLOGY-OXFORD | 2004年 / 13卷 / 2-3期

关键词：

colon cancer; rectal cancer; adjuvant therapy; combined therapy; elderly;

D O I：

10.1016/j.suronc.2004.09.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Colorectal cancer is one of the most frequent causes of cancer deaths. Survival for locoregional colorectal cancer is about 70% overall and 30-60% in stage III patients. Several randomized trials have shown that adjuvant chemotherapy can increase this survival rate. 5-Fluorouracil-based chemotherapy is strongly recommended in this context. There are still some questions about the setting in which patients should be treated as well as the optimal treatment. New data for different schedules and combinations are now available. Physicians have to choose between the different options now available to offer the best treatment to their patients. This Review analyses the current options for adjuvant therapy in colon and rectal cancer. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：63 / 73

页数：11

共 80 条

[21]

DEBRABANDER M, 1992, ANTICANCER RES, V12, P177

[22]

ENKER WE, 2002, GASTROINTESTINAL ONC, P781

[23] Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer [J].

Erlichman, C ;

O'Connell, M ;

Kahn, M ;

Marsoni, S ;

Torri, V ;

Tardio, B ;

Zaniboni, A ;

Pancera, G ;

Martignoni, G ;

Labianca, R ;

Barni, A ;

Seitz, JF ;

Milan, C ;

Bedenne, L ;

Giovannini, M ;

Letreut, YP ;

Skillings, J ;

Shepard, L ;

Zee, B ;

Petrioli, R ;

Francini, G .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1356-1363

[24]

ERLICHMAN C, 2002, COLORECTAL CANC CLIN, P135

[25] POSTOPERATIVE ADJUVANT CHEMOTHERAPY OR RADIATION-THERAPY FOR RECTAL-CANCER - RESULTS FROM NSABP PROTOCOL R-01 [J].

FISHER, B ;

WOLMARK, N ;

ROCKETTE, H ;

REDMOND, C ;

DEUTSCH, M ;

WICKERHAM, DL ;

FISHER, ER ;

CAPLAN, R ;

JONES, J ;

LERNER, H ;

GORDON, P ;

FELDMAN, M ;

CRUZ, A ;

LEGAULTPOISSON, S ;

WEXLER, M ;

LAWRENCE, W ;

ROBIDOUX, A .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01) :21-29

[26]

Furner SE, 1997, GERIATRIC MED, P37

[27] Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much? [J].

Gill, S ;

Loprinzi, CL ;

Sargent, DJ ;

Thomé, SD ;

Alberts, SR ;

Haller, DG ;

Benedetti, J ;

Francini, G ;

Shepherd, LE ;

Seitz, JF ;

Labianca, R ;

Chen, W ;

Cha, SS ;

Heldebrant, MP ;

Goldberg, RM .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1797-1806

[28]

Gray R, 1997, JNCI-J NATL CANCER I, V89, P497

[29]

Gray R, 2001, LANCET, V358, P1291

[30] AXIS - A SUITABLE CASE FOR TREATMENT [J].

GRAY, R ;

JAMES, R ;

MOSSMAN, J ;

STENNING, S .

BRITISH JOURNAL OF CANCER, 1991, 63 (06) :841-845

← 1 2 3 4 5 6 7 8 →